Merck & Co., Inc. MRK
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 5.07B | -1.34B | -4.24B | 2.96B | 5.79B |
| Total Depreciation and Amortization | 1.51B | 1.47B | 1.40B | 1.42B | 1.10B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -89.00M | 4.81B | 8.37B | 795.00M | -375.00M |
| Change in Net Operating Assets | 71.00M | 423.00M | -1.61B | -2.32B | 1.31B |
| Cash from Operations | 6.56B | 5.37B | 3.92B | 2.86B | 7.82B |
| Capital Expenditure | -1.04B | -893.00M | -991.00M | -1.03B | -987.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -630.00M | -5.84B | -8.78B | -10.04B | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 351.00M | 1.13B | -440.00M | -126.00M | 704.00M |
| Cash from Investing | -1.32B | -5.60B | -10.21B | -11.20B | -283.00M |
| Total Debt Issued | 0.00 | 10.90B | 1.06B | 7.86B | 5.96B |
| Total Debt Repaid | 0.00 | -6.01B | -1.14B | -2.00M | -1.00M |
| Issuance of Common Stock | 247.00M | 43.00M | 157.00M | 47.00M | 14.00M |
| Repurchase of Common Stock | -653.00M | -757.00M | -874.00M | -1.25B | -1.32B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.10B | -2.14B | -2.11B | -2.02B | -2.03B |
| Other Financing Activities | 73.00M | -270.00M | -80.00M | 121.00M | 17.00M |
| Cash from Financing | -2.43B | 1.76B | -2.98B | 4.75B | 2.64B |
| Foreign Exchange rate Adjustments | -46.00M | -37.00M | -19.00M | 23.00M | 10.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.76B | 1.49B | -9.29B | -3.57B | 10.19B |